DECR1 Antibody [Alexa Fluor® 647]

• Reactivity: Hu
• Applications: WB
• Clonality: Polyclonal
• Host: Sheep
• Conjugate: Alexa Fluor 647

DECR1 Antibody [Alexa Fluor® 647] Summary

• Immunogen: E. coli-derived recombinant human DECR1
  Met233-Ser335
  Accession # Q16698
• Specificity: Detects human DECR1 in direct ELISAs and Western blots.
• Isotype: IgG
• Clonality: Polyclonal
• Host: Sheep
• Purity Statement: Antigen Affinity-purified

Applications/Dilutions

• Dilutions:
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for DECR1 Antibody [Alexa Fluor® 647]

• 2,4-dienoyl CoA reductase 1, mitochondrial
• 4-enoyl-CoA reductase [NADPH]
• 4-enoyl-CoA reductase
• DECR
• DECR1
• DECR2,4-dienoyl-CoA reductase [NADPH]2,4-dienoyl-CoA reductase, mitochondrial
• EC 1.3.1.34
• NADPH
• SDR18C1
• short chain dehydrogenase/reductase family 18C, member 1

Background

DECR-1 (2, 4-DiEnol CoA Reductase, mitochondrial) is a 33-36 kDa member of the DECR subfamily, short-chain dehydrogenase/reductase family of molecules. It is a mitochondrial enzyme that is expressed in multiple cell types, particularly those involved in oxidative degradation of fatty acids. Fatty acids provide energy following their degradation by four enzymes that comprise the beta -oxidation cycle. The optimal configuration for fatty acids in this cycle is one of saturation. However, many fatty acids that appear before this cycle are unsaturated, and it is necessary to transform them into a suitable configuration for processing. DECR-1 converts a two double-bonded substrate into a one double-bonded substrate, which subsequently undergoes isomerization and entry into the beta -oxidation cycle. Human DECR-1 is 335 amino acids (aa) in length. It contains a mitochondrial targeting sequence (aa 1-34), and a 301 aa mature region that possesses one catalytic site (aa 57-302). There are two potential acetylation sites at Lys110 and Lys230. DECR-1 forms homotetramers. One potential isoform variant shows an alternative start site at Met93 coupled to a deletion of aa 292-335. Over aa 233-335, human DECR-1 shares 87% aa sequence identity with mouse DECR-1.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.